Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Sell
49
HQY Quote, Financials, Valuation and Earnings
Last price:
$92.76
Seasonality move
:
6.31%
Day range:
$92.06 - $93.68
52-week range:
$74.07 - $116.65
Dividend yield:
0%
P/E ratio:
42.52x
P/S ratio:
6.33x
P/B ratio:
3.71x
Volume:
410.1K
Avg. volume:
886.6K
1-year change:
-3.66%
Market cap:
$7.9B
Revenue:
$1.2B
EPS (TTM):
$2.18
Analysts' Opinion
-
Consensus RatingHealthEquity, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $121.36, HealthEquity, Inc. has an estimated upside of 31.06% from its current price of $92.78.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $100.00 representing 100% downside risk from its current price of $92.78.
Fair Value
-
According to the consensus of 10 analysts, HealthEquity, Inc. has 31.06% upside to fair value with a price target of $121.36 per share.
HQY vs. S&P 500
-
Over the past 5 trading days, HealthEquity, Inc. has underperformed the S&P 500 by -2.48% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
HealthEquity, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
HealthEquity, Inc. has grown year-over-year revenues for 18 quarters straight. In the most recent quarter HealthEquity, Inc. reported revenues of $322.2M.
Earnings Growth
-
HealthEquity, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter HealthEquity, Inc. reported earnings per share of $0.59.
Enterprise value:
8.6B
EV / Invested capital:
2.73x
Price / LTM sales:
6.33x
EV / EBIT:
26.47x
EV / Revenue:
6.70x
PEG ratio (5yr expected):
0.43x
EV / Free cash flow:
23.84x
Price / Operating cash flow:
22.53x
Enterprise value / EBITDA:
17.95x
Gross Profit (TTM):
$793.2M
Return On Assets:
5.56%
Net Income Margin (TTM):
14.86%
Return On Equity:
9.01%
Return On Invested Capital:
5.97%
Operating Margin:
24.79%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Income Statement | ||||||
| Revenue | $971M | $1.2B | $1.3B | $300.4M | $322.2M | |
| Gross Profit | $498.7M | $643.4M | $793.2M | $168.7M | $201.1M | |
| Operating Income | $105.3M | $199.7M | $326.6M | $54.1M | $79.9M | |
| EBITDA | $260.9M | $360.9M | $481.8M | $94.8M | $118.6M | |
| Diluted EPS | $0.34 | $1.10 | $2.18 | $0.06 | $0.59 | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $764.1M | $332.2M | $474.4M | $495.2M | $498.7M | |
| Total Assets | $3.1B | $3.1B | $3.1B | $3.5B | $3.4B | |
| Current Liabilities | $107.1M | $110.4M | $96.2M | $154.5M | $120.6M | |
| Total Liabilities | $1.2B | $1.2B | $1.1B | $1.4B | $1.3B | |
| Total Equity | $1.9B | $1.9B | $2B | $2.1B | $2.1B | |
| Total Debt | $997.9M | $987.5M | $924.9M | $1.1B | $1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $221.2M | $341.2M | $414.9M | $90.6M | $138.6M | |
| Cash From Investing | -$45.1M | -$503.2M | -$52.3M | -$12.9M | -$11.4M | |
| Cash From Financing | -$52.3M | $150.1M | -$375.6M | -$82.4M | -$122.4M | |
| Free Cash Flow | $176.2M | -$162M | $362.7M | $77.7M | $127.2M | |
HQY
Sector
Market Cap
$7.9B
$27.9M
Price % of 52-Week High
79.54%
50.56%
Dividend Yield
0%
0%
Shareholder Yield
3.67%
-1.55%
1-Year Price Total Return
-3.66%
-17.49%
Beta (5-Year)
0.176
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$93.94
200-day SMA
Sell
Level
$94.65
Bollinger Bands (100)
Sell
Level
90.21 - 98.59
Chaikin Money Flow
Buy
Level
70M
20-day SMA
Sell
Level
$95.43
Relative Strength Index (RSI14)
Sell
Level
39.58
ADX Line
Sell
Level
11.51
Williams %R
Neutral
Level
-75.5556
50-day SMA
Sell
Level
$97.02
MACD (12, 26)
Sell
Level
-1.37
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
116.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.7561)
Buy
CA Score
(Annual)
Level (0.4937)
Buy
Beneish M-Score
(Annual)
Level (-2.7443)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.1858)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.
Stock Forecast FAQ
In the current month, HQY has received 8 Buy ratings 2 Hold ratings, and 0 Sell ratings. The HQY average analyst price target in the past 3 months is $121.36.
-
Where Will HealthEquity, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that HealthEquity, Inc. share price will rise to $121.36 per share over the next 12 months.
-
What Do Analysts Say About HealthEquity, Inc.?
Analysts are divided on their view about HealthEquity, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that HealthEquity, Inc. is a Sell and believe this share price will drop from its current level to $100.00.
-
What Is HealthEquity, Inc.'s Price Target?
The price target for HealthEquity, Inc. over the next 1-year time period is forecast to be $121.36 according to 10 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is HQY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for HealthEquity, Inc. is a Buy. 8 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HQY?
You can purchase shares of HealthEquity, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase HealthEquity, Inc. shares.
-
What Is The HealthEquity, Inc. Share Price Today?
HealthEquity, Inc. was last trading at $92.76 per share. This represents the most recent stock quote for HealthEquity, Inc.. Yesterday, HealthEquity, Inc. closed at $92.78 per share.
-
How To Buy HealthEquity, Inc. Stock Online?
In order to purchase HealthEquity, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get HQY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HQY
Sector
P/E ratio
42.52x
23.75x
PEG ratio
0.43x
-0.01x
P/B ratio
3.71x
1.81x
Price / LTM sales
6.33x
1.59x
Growth Metrics
HQY
Sector
Revenue growth
7.23%
4.6%
Earnings growth
824.42%
10.88%
Revenue (5-year growth)
17.66%
6.45%
Earnings forecast
$0.91
-$0.21
Profitability
HQY
Sector
Profitability FY 2024
$692.6M
$3.6M
Return on invested capital
5.97%
-31.84%
Return on assets
5.56%
-27.96%
Return on equity
9.01%
-37.63%
Earnings Date
Last Earnings Date
Dec
3
Next Earnings Date
Mar
17
Estimated Next Earnings Date
Mar
4
Balance Sheet
HQY
Sector
Total cash
$309.3M
$26.3M
Short term investments
--
$25.7M
Total assets
$3.5B
$76.9M
Long term debt
$1B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 27.03% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is up 18.01% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 18.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
